CMPX Stock Analysis: Buy, Sell, or Hold?
CMPX - Compass Therapeutics, Inc. Common Stock
$1.89
-0.02 (-1.31%)
▼
5d:
-9.38%
30d:
-16.96%
90d:
-3.83%
HOLD
LOW Confidence
Analysis Updated: Jul 31, 2026 12:00 AM ET
Earnings: Aug 10, 2026
5d
Smart Money Accumulation
None View Scanner →
Strength: 5.7/10
Get Alerted When CMPX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: CMPX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: CMPX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: CMPX is currently trading at $1.89, which is considered oversold relative to its 30-day fair value range of $2.00 to $2.26.
Technical Outlook: Technically, CMPX is in a strong uptrend. The price is currently testing key support at $1.85. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $8.50 (+350.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, CMPX is in a strong uptrend. The price is currently testing key support at $1.85. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $8.50 (+350.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$2.00 -
$2.26
Company Quality Score
61/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
82.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 350.9% below Wall St target ($8.50)
- CAUTION: Recommendation downgraded due to -9.4% 5-day decline
Trading Range Analysis
30-Day Trading Range
$2.00 -
$2.26
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$1.85
Resistance Level
$2.23
Current Trend
Strong Uptrend
Technical data as of
Aug 3, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-4.08
Wall Street Target
$8.50
(+350.9%)
Share & Embed Analysis
Last updated: August 04, 2026 2:27 AM ET
Data refreshes hourly during market hours. Next update: 3:27 AM
Data refreshes hourly during market hours. Next update: 3:27 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CMPX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$87 | 53 HOLD |
|
INSM
Insmed Inc |
STRONG BUY
21 analysts |
$196 | 47 HOLD |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$108 | 60 HOLD |
|
CRNX
Crinetics Pharmaceutical… |
STRONG BUY
17 analysts |
$86 | 47 HOLD |
|
BHVN
Biohaven Ltd. |
STRONG BUY
16 analysts |
$23 | 51 HOLD |
